IVRO logo

InVitro International, Inc. Stock Price

OTCPK:IVRO Community·US$1.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

IVRO Share Price Performance

US$0.087
0.00 (5.42%)
US$0.087
0.00 (5.42%)
Price US$0.087

IVRO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and good value.

4 Risks
2 Rewards

InVitro International, Inc. Key Details

US$811.3k

Revenue

US$157.8k

Cost of Revenue

US$653.5k

Gross Profit

US$546.8k

Other Expenses

US$106.7k

Earnings

Last Reported Earnings
Sep 30, 2024
Next Reporting Earnings
n/a
0.0048
80.55%
13.15%
0%
View Full Analysis

About IVRO

Founded
1985
Employees
n/a
CEO
W. Ulmer
WebsiteView website
www.invitrointl.com

InVitro International, Inc. develops test kits for non-animal testing applications in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivity based on a biomembrane and chemical detection systems. The company also provides customized technology services for Irritection Assay System installation and testing process, and independent testing laboratory services for irritancy and corrosivity testing requirements, as well as consultation and assistance services. Its products are principally used in cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, hazardous waste, and transportation industries. InVitro International, Inc. was incorporated in 1985 and is headquartered in Placentia, California.

Recent IVRO News & Updates

No updates

Recent updates

No updates